Nanox Imaging is trading at $0.22, with a -10.47% change; no clear catalyst has been identified for the November 6 decline. - No fresh company-specific announcement has been identified, and shares had already fallen in recent sessions. - Nanox Imagingβs November 2 business update included preliminary third-quarter sales below analyst estimates. - Healthcare was weaker, with XLV down 1.48%, but available evidence does not establish sector weakness as the cause.